Clinical Trials Sponsored by Profact, Inc.

Total 35704 results

Profact, Inc.

Terminated

An Outpatient Study Investigating Non-prescription Treatments for COVID-19 (PROFACT-01)

COVID-19

United States
Pharmaceutical Project Solutions, Inc.

Completed

Topical Anesthetic for Procedures Through the Nose

Drug Reaction to Analgesic Nos

United States
Pharmaceutical Project Solutions, Inc.

Not yet recruiting

Pharmacokinetics, Safety, and Tolerability Study of GOPRELTO® Nasal Solution

ENT Disorder
Pharmaceutical Project Solutions, Inc.

Completed

Phase I Pharmacokinetic Study of RX0041-2

Drug Reaction to Analgesic Nos
TransDerm, Inc.
Pachyonychia Congenita Project

Completed

Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)

Pachyonychia Congenita

United States
GrowBaby Life Project
Metagenics, Inc.; OmegaQuant, LLC

Not yet recruiting

Select Nutrient and Gene Variant Analysis in a Targeted Diet and Lifestyle Intervention Reduces Preterm Birth (SNGLI-PTB)

Premature Birth | Pre-Eclampsia | Small for Gestational Age Infant

United States
Pharmaceutical Project Solutions, Inc.
Cognitive Research Corporation

Completed

PK Study of Intranasal RX0041-002 in Subjects With Severe Renal Impairment and Normal Renal Function

Healthy

United States
Pharmaceutical Project Solutions, Inc.
Cognitive Research Corporation

Completed

Pharmacokinetic Study of Intranasal RX0041-002 in Hepatic-Impaired Individuals and Subjects With Normal Hepatic Function

Analgesic Allergy

United States
Prolacta Bioscience

Completed

Safety Study of Human Milk Oligosaccharides in Healthy Adults

Healthy

United States
Prolacta Bioscience

Completed

Dietary Supplement With and Without a Probiotic and/or Antibiotic

Healthy Adults

United States
Proacta, Incorporated

Terminated

Randomized Phase 1/2 Open-Label Trial of PR104 and Sorafenib in Patients With Advanced Hepatocellular Carcinoma (HCC)

Hepatocellular Carcinoma

United States, Taiwan, Singapore, Hong Kong
Proacta, Incorporated

Terminated

PR104 in Treating Patients With Previously Untreated or Relapsed Small Cell Lung Cancer

Lung Cancer

United States
Proacta, Incorporated

Unknown

PR104 in Treating Patients With Refractory/Relapsed Acute Leukemia

Acute Lymphocytic Leukemia | Acute Myelogenous Leukemia

United States
Prolacta Bioscience

Completed

Evaluation of Prolact-Plus Human Milk Fortifier

Infant, Very Low Birth Weight

United States
Prolacta Bioscience

Terminated

A Study of Safety of PBCLN-003 Following Antibiotic Therapy in Subjects With C.Difficile-associated Diarrhea

Clostridium Difficile Diarrhea

United States
Proacta, Incorporated

Terminated

Randomized, Multi-center, Open-label, Study of PR104 Versus PR104/Docetaxel in Non-Small Cell Lung Cancer (NSCLC)

Non-Small Cell Lung Cancer

United States, Canada, New Zealand
Proacta, Incorporated

Completed

PR104 and G-CSF in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

United States, New Zealand
Proacta, Incorporated

Completed

A Phase I Dose Escalation Trial of PR104 Given Weekly in Subjects With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

New Zealand
Proacta, Incorporated

Completed

PR-104 and Docetaxel or Gemcitabine in Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

New Zealand, United States
Prolacta Bioscience

Completed

Randomized Study of Human-Milk Based Nutrition Versus Formula in Premature Infants

Infant, Very Low Birth Weight

United States, Austria
Prolacta Bioscience

Recruiting

Study To Evaluate The Safety And Efficacy of PBCLN-010 In Combination With PBCLN-014 in Participants Receiving Allogeneic Hematopoietic Cell Transplantation

Hematologic Malignancy

United States
Prolacta Bioscience

Completed

Dietary Supplement With and Without a Probiotic

Healthy Adult Subjects

United States
Proacta, Incorporated

Terminated

A Dose Escalation Trial of PR610 Treating Patients With Solid Tumors

Unspecified Adult Solid Tumor, Protocol Specific

New Zealand, United States
ViiV Healthcare
GlaxoSmithKline; Pharmaceutical Product Development (PPD), Inc

Completed

To Assess the Relative Bioavailability (BA) of TRIUMEQ® and Dolutegravir and Lamivudine (DTG/3TC) Pediatric Dispersible Tablet Formulations in Healthy Volunteers

HIV Infections

United States
Alzheimer's Prevention and Reversal Project, Inc.
Four Winds Foundation

Not yet recruiting

Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment (EVANTHEA)

Mild Cognitive Impairment | Dementia, Mild

United States
Cancer Advances Inc.
Clinical Project Services; MPS Research Unit

Completed

Dose-ranging Study to Evaluate Antibody Response to G17DT in Patients With Gastric Cancer

Gastric Cancer
Central Medicare Sdn. Bhd.
Consumer Product Testing Company, Inc.

Completed

Skin Sensitization Test (Modified Draize-95 Test)

Skin Sensitisation

United States
Valhalla Project Niagara

Recruiting

Residential Retreat for Veterans and First-responders

PTSD

Canada
Pachyonychia Congenita Project

Recruiting

International Pachyonychia Congenita Research Registry (IPCRR)

Pachyonychia Congenita

United States
Bandim Health Project

Completed

A Second Dose of Measles Vaccine (MV) in the Second Year of Life

Child Mortality | Child Morbidity

Guinea-Bissau
Bandim Health Project

Enrolling by invitation

Measles Vaccination at Health System Contacts

Mortality | Measles Vaccine | Hospital Admission | Non-specific (Heterologous) Effects of Vaccines

Guinea-Bissau
Pediatrix
Prolacta Bioscience

Withdrawn

Nutritional Content of Breast Milk From Mothers of Premies

Prematurity | Nutrition

United States
Bandim Health Project

Unknown

Additional Measles Vaccine at 4 Months of Age

Measles Infection

Guinea-Bissau
Bandim Health Project

Unknown

Vitamin A Supplementation With Routine Childhood Vaccines and Mortality and Morbidity

Mortality | Morbidity

Guinea-Bissau
Bandim Health Project

Completed

Different Doses of Vitamin A Supplementation and Male and Female Morbidity and Mortality

Mortality | Morbidity

Guinea-Bissau
Bandim Health Project

Unknown

The Effect of Paracetamol in the Treatment of Non-severe Malaria in Children in Guinea-Bissau

Malaria | Falciparum

Guinea-Bissau
Bandim Health Project

Completed

Impact of Exclusive Breast-Feeding in Guinea Bissau

Nutritional Status

Guinea-Bissau
Bandim Health Project

Completed

Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria

Malaria | Effectiveness

Guinea-Bissau
Bandim Health Project

Active, not recruiting

OPV as Potential Protection Against COVID-19

Mortality | COVID | Morbidity | Poliovirus Vaccine, Oral | Non-Specific Effects of Vaccines

Guinea-Bissau
Bandim Health Project

Completed

Artemether-Lumefantrine Effectiveness in Guinea-Bissau 2

Malaria

Guinea-Bissau
Bandim Health Project

Completed

Low Birth Weight Follow-up

Low Birth Weight | Non Specific Effects of Vaccine | Bacillus-Calmette-Guerin | Maternal Immunisation

Guinea-Bissau
Bandim Health Project

Terminated

A Randomized Trial of Providing BCG Vaccination Immediately

Early Neonatal Mortality

Guinea-Bissau
Bandim Health Project

Unknown

Investigating the Mortality and the Morbidity Impact of Oral Polio Vaccine at Birth

Healthy | Infant, Newborn

Guinea-Bissau
Bandim Health Project

Completed

Chloroquine and Coartem for Treatment of Symptomatic Children With Plasmodium Falciparum in Guinea Bissau

Malaria, Falciparum

Guinea-Bissau
Pachyonychia Congenita Project

Completed

Study of TD101, a Small Interfering RNA (siRNA) Designed for Treatment of Pachyonychia Congenita

Pachyonychia Congenita

United States
Bandim Health Project

Completed

Different Doses of Vitamin A and Childhood Morbidity and Mortality

Mortality | Morbidity

Guinea-Bissau
Documenting Hope Project

Recruiting

FLIGHT Study for Childhood Chronic Illness

Chronic Illnesses, Multiple

United States
Bandim Health Project

Completed

Artemether-Lumefantrine Effectiveness in Guinea-Bissau

Malaria

Guinea-Bissau
Parent Project, Italy

Completed

To Compare the Pharmacokinetics Profiles of ISO 20, IBU 200 and IBU Plus ISO Combinations 200 + 20 (ISOFEN1)

Duchenne Muscular Dystrophy (DMD)

Italy
Bandim Health Project

Unknown

mHealth to Increase Measles Immunization - a Randomized Controlled Trial in Guinea-Bissau (mimi)

Measles

Guinea-Bissau

Clinical Trials Sponsored by Profact, Inc.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Saudi Arabia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations